S&P Global, the world’s leading authority of ESG ratings and research, recently released “The S&P Global Sustainability Yearbook 2026.” Microbio Group delivered an outstanding performance: its subsidiary Oneness Biotech Co., Ltd. (4743) has been selected for the fourth consecutive year, while Diamond BioFund Inc. (6901) and Microbio Co., Ltd. (4128) made their debut on...Read More
No 1 Date of announcement 2026/02/22 Time of announcement 10:27:58 Addresser Shu-Ling Cheng Addresser’s Position President Addresser’s Phone Number 02-26558860 Subject Bonvadis topical cream received medical device marketing authorization approval for all indications in wounds by INVIMA Colombia. To which item it meets Subparagraph 10 Date of events 2026/02/22 Statement Date of occurrence of...Read More
No 1 Date of announcement 2026/02/07 Time of announcement 11:34:57 Addresser Shu-Ling Cheng Addresser’s Position President Addresser’s Phone Number 02-26558860 Subject Oneness ON101 cream promotes healing of an essential thrombocythemia–associated toe ulcer, with findings published in the SCI journal, Journal of Wound Care To which item it meets Subparagraph 53 Date of events 2026/02/07...Read More
No 1 Date of announcement 2026/01/31 Time of announcement 17:03:02 Addresser Shu-Ling Cheng Addresser’s Position President Addresser’s Phone Number 02-26558860 Subject The medical device registration application of Bonvadis for all indications of wounds has been accepted by INVIMA Colombia. To which item it meets Subparagraph 10 Date of events 2026/01/31 Statement Date of occurrence...Read More
No 1 Date of announcement 2026/01/13 Time of announcement 17:31:57 Subject Oneness Board of Directors resolved to convene the Annual Shareholders’ Meeting of 2026. To which item it meets paragraph 12 Date of events 2026/01/13 Statement Date of the board of directors’ resolution：2026/01/13 Shareholders meeting date：2026/05/20 Shareholders meeting location：8F., No. 11, Zhongshan S. Rd.,...Read More
No 1 Date of announcement 2026/01/05 Time of announcement 17:11:53 Addresser Shu-Ling Cheng Addresser’s Position President Addresser’s Phone Number 02-26558860 Subject Bonvadis topical cream received medical device marketing authorization approval for all indications in wounds by EDA Egypt. To which item it meets Subparagraph 10 Date of events 2026/01/05 Statement Date of occurrence of...Read More
No 1 Date of announcement 2025/12/30 Time of announcement 16:41:37 Subject Oneness Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference To which item it meets paragraph 12 Date of events 2026/01/16 Statement Date of institutional investor conference: 2026/01/16 Time of institutional investor conference: 01:30 (CST) Location of institutional investor conference: The...Read More
No 1 Date of announcement 2025/12/19 Time of announcement 17:51:27 Addresser Shu-Ling Cheng Addresser’s Position President Addresser’s Phone Number 02-26558860 Subject Bonvadis topical cream received medical device import license for all indications in wounds for India To which item it meets Subparagraph 10 Date of events 2025/12/19 Statement Date of occurrence of the event:2025/12/19...Read More
No 1 Date of announcement 2025/12/17 Time of announcement 16:39:53 Subject Oneness announces information about the third investor conference in 2025. To which item it meets paragraph 12 Date of events 2025/12/24 Statement Date of institutional investor conference: 2025/12/24 Time of institutional investor conference: 15:00 (GMT+8) Location of institutional investor conference: Online Investor Conference...Read More
No 1 Date of announcement 2025/11/12 Time of announcement 16:54:15 Subject Oneness Biotech Co., Ltd. receives a Canadian patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets Subparagraph 53 Date of events 2025/11/12 Statement Date of occurrence of the event：2025/11/12 Company name: ONENESS BIOTECH...Read More
